Roche Translational Neuroscience Symposium
Better tools needed to assess clinical trials
Emily SingerThe past few years have seen an unprecedented number of clinical trials for experimental drugs to treat autism-related disorders, most notably for fragile X syndrome. But as the trials progress, scientists are calling for better methods to measure the drugs’ effectiveness.
Trials and tribulations
Emily SingerClinical trials for fragile X drugs should include a behavioral therapy component, says a parent of a child with the disorder.
Compensatory mechanisms
Emily SingerIdentifying genetic and other factors that protect children at risk of autism from developing the disorder could provide new avenues for treatment.
Debate over quality of adult-derived stem cells rages on
Emily SingerAs the use of induced pluripotent stem cells grows, researchers are searching for ways to make them behave more predictably.
Complex case
Emily SingerMultiple levels of complexity make it challenging to develop drugs to treat autism.
Fast-forward
Emily SingerIn the last three years, autism researchers have gone from sequencing single genes to whole exomes, as highlighted at the Translational Neuroscience Symposium in Switzerland last week.
